A Study to Evaluate Pharmacokinetics, Pharmacodynamics and Tissue Concentrations of Epelsiban

Clinical trial NCT02213029 · TERMINATED

Trial details

NCT number: NCT02213029
Sponsor: GlaxoSmithKline
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Embryo Transfer

Start date: 2014-08-28
Primary completion: 2016-02-07
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.